Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR | Market Cap | 828.46B +22.5% |
| Revenue (ttm) | 336.53B +6.1% |
| Net Income | 35.05B +0.5% |
| EPS | 60.34 +0.9% |
| Shares Out | n/a |
| PE Ratio | 23.64 |
| Forward PE | 18.51 |
| Dividend | 4.00 (0.28%) |
| Ex-Dividend Date | Aug 8, 2025 |
| Volume | 26,271 |
| Open | 1,425.00 |
| Previous Close | 1,430.90 |
| Day's Range | 1,421.00 - 1,449.50 |
| 52-Week Range | 1,017.00 - 1,550.00 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 1,511.93 (+5.55%) |
| Earnings Date | May 21, 2026 |
About Aurobindo Pharma
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretrovira... [Read more]
Financial Performance
In fiscal year 2026, Aurobindo Pharma's revenue was 336.53 billion, an increase of 6.08% compared to the previous year's 317.24 billion. Earnings were 35.05 billion, an increase of 0.54%.
Financial StatementsNews
Pharma sector stocks today, May 27: Panacea Biotech rises 2.83%, Wockhardt up 2.71%, Aurobindo Pharma down 0.17%
Pharmaceutical stocks traded mixed during the morning session on May 27, 2026. While some stocks posted decent gains, a few names saw mild selling pressure. The BSE Healthcare index rose…
Aurobindo Pharma's Eugia facility receives OAI classification from US FDA
Aurobindo Pharma has announced that its wholly owned subsidiary, Eugia Pharma Specialities Ltd., has received an 'official action indicated' (OAI) classification from the US Food and Drug Administrati...
Aurobindo Pharma expands European footprint with new subsidiary in France
Aurobindo Pharma on Friday said its wholly owned step-down subsidiary, Agile Pharma BV, has incorporated a new wholly owned subsidiary in France named Arrow Pharma Production SAS, marking another step...
Pharma sector stocks today, May 22: Aurobindo Pharma falls 4.11%, Zydus Lifesciences rises 0.92%, Alembic Pharma up 1.06%
Pharmaceutical stocks traded mixed on May 22, 2026, during the morning session. While some stocks posted modest gains, a few names, including Aurobindo Pharma, witnessed sharp declines. The BSE Health...
Aurobindo Pharma Transcript: Q4 25/26
Record FY 2026 revenue and EBITDA margins were achieved, with strong growth across all segments and geographies. Outlook for FY 2027 is robust, targeting higher margins and double-digit growth in Europe, while biosimilars and CDMO strategies are set to drive long-term expansion.
Aurobindo Pharma Quarterly report: Q4 2026
Aurobindo Pharma has published its Q4 2026 quarterly earnings report on May 21, 2026.
Aurobindo Pharma Slides: Q4 2026
Aurobindo Pharma has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 21, 2026.
Top stocks for trade today, May 22: ITC, LIC, GAIL India, Max Healthcare, Paytm, Aurobindo Pharma and more
Indian stock markets are expected to track company earnings, block deal developments, and sector-specific triggers on May 22. Several companies, including ITC Limited, Life Insurance Corporation of In...
Aurobindo Pharma reports ₹8,853 crore revenue for Q4FY26 with 5.6% growth
Aurobindo Pharma Limited has announced its consolidated financial results for the fourth quarter and the fiscal year ending March 31, 2026. The company reported a 5.6% year-on-year increase in revenue...
Aurobindo Pharma Q4 Results: Shares jump over 2% ahead of earnings announcement
Shares of Aurobindo Pharma gained over 2% in intraday trade on Thursday ahead of the company’s Q4 FY26 results announcement, with investors closely tracking the stock ahead of its earnings…
Pharma sector stocks today, May 21: Panacea Biotech up 1.57%, Aurobindo Pharma jumps 1.37%, Torrent Pharma gains 1.48%
Pharmaceutical stocks traded mixed on May 21, 2026, during the morning session. While some stocks posted decent gains, several others saw mild selling pressure. The BSE Healthcare index rose 0.58%…
Top Q4 results today, May 21: LICI, ITC, Aurobindo Pharma, GAIL, LG Electronics India among key companies to announce earnings
Around 190 companies are scheduled to announce their March quarter (Q4FY26) results on May 21. Investors and analysts are expected to track revenue, profit, operating margins and management commentary...
Aurobindo Pharma promoters face Rs 6.53 crore settlement order
The Hon’ble High Court of Telangana, Hyderabad, has dismissed a writ petition filed by the promoters of Aurobindo Pharma regarding a settlement order issued by the Securities and Exchange Board…
Aurobindo Pharma subsidiary CuraTeQ Biologics receives CDSCO marketing authorisation for Bevqolva
CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has secured marketing authorisation from the Central Drugs Standard Control Organization (CDSCO) for its bevacizumab b...
Aurobindo Pharma's Unit-VII classified as 'Voluntary Action Indicated' by US FDA
Aurobindo Pharma's Unit-VII, an oral solid dosage manufacturing unit located in Jedcherla, Telangana, has been classified as 'Voluntary Action Indicated' (VAI) by the United States Food and Drug Admin...
Top Stocks For Trade Today, May 5: Adani Ports, ONGC, Oil India, Tata Technologies, Petronet LNG, Aurobindo Pharma and more
Indian markets may see stock-specific activity driven by earnings updates, commodity price movement, and corporate developments. Adani Ports and Special Economic Zone will be in focus after Capital In...
Aurobindo Pharma announces resignation of Dr. Sanjay Chaturvedi as CEO of subsidiary
Aurobindo Pharma has announced the resignation of Dr. Sanjay Chaturvedi from his position as Chief Executive Officer of Apitoria Pharma Private Limited, a wholly owned subsidiary of the company. Dr.…
Aurobindo Pharma's CuraTeQ Biologics receives Health Canada nod for Bevqolva biosimilar
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, has secured a Notice of Compliance (NOC) from Health Canada for its bevacizumab biosimilar, Bevqolva. The approval from Health Canada’...
Aurobindo Pharma receives USFDA approval for Dextromethorphan Polistirex suspension
Aurobindo Pharma has secured final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dextromethorphan Polistirex Extended-Release Oral Suspension, 30 mg/5 mL (OTC). Thi...
Aurobindo Pharma receives USFDA approval for Glycerol Phenylbutyrate Oral Liquid
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL. This product is bioequivale...
HAL, Trent & more: Top stocks on brokers' radar today
Analysts are bullish on Adani Enterprises, HAL, and Trent, citing growth drivers like new energy and engine co-production. Aurobindo Pharma's biologics expansion shows promise but financial gains are ...
Stocks to watch on brokerages today, April 16: Aurobindo Pharma, Adani Enterprises, HAL, ICICI Lombard in focus
Brokerage firms have shared fresh views on several key Indian stocks on April 16, highlighting developments across pharmaceuticals, infrastructure, cement, retail, insurance, NBFCs and defence. Stocks...
Top stocks for trade today, April 16: Aurobindo Pharma, ICICI Lombard, HDB Financial, Tejas Networks, Delhivery, RailTel in focus
Indian markets are expected to see stock-specific action on April 16, with several companies making headlines across sectors including pharma, financials, logistics, and infrastructure. Here are the k...
Aurobindo Pharma subsidiary to invest up to USD 175 million in new manufacturing facility
TheraNym Biologics Private Limited, a subsidiary of Aurobindo Pharma, has announced an expansion of its existing contract manufacturing operations (CMO) agreement with Merck Sharpe & Dohme Singapore T...
Top stocks for trade today, April 8: Aurobindo Pharma, Lupin, Angel One, Infosys, PB Fintech and more
Indian equity markets are expected to react to a mix of company-specific developments and global cues, particularly easing crude oil prices following a temporary ceasefire in West Asia. Here’s a…